Healthy Living
Dr Ross Walker speaks with Professor John Wentworth, Endocrinologist and Senior Clinical Research Fellow at St Vincent's Institute of Medical Research. We discuss the TGA’s historic registration of Tzield, the very first non-insulin medicine designed to delay the onset of clinical Type 1 diabetes. To find out more go to https://breakthrought1d.org.au/news/tzield-approved-in-australia/ [https://breakthrought1d.org.au/news/tzield-approved-in-australia/] See omnystudio.com/listener [https://omnystudio.com/listener] for privacy information.
100 Folgen
Kommentare
0Sei die erste Person, die kommentiert
Melde dich jetzt an und werde Teil der Healthy Living-Community!